ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
ANI Pharmaceuticals (ANIP) has announced its participation in the upcoming Guggenheim Biotech Conference in New York City. The company's President and CEO Nikhil Lalwani and CFO Stephen Carey will conduct a fireside chat on Wednesday, February 5, 2025, at 2:00pm EST.
The presentation will be available through a live webcast, which can be accessed through ANI Pharmaceuticals' website under the Investors section's Events and Presentations area. For those unable to attend, the webcast recording will remain accessible for 60 days following the event.
ANI Pharmaceuticals (ANIP) ha annunciato la sua partecipazione alla prossima Guggenheim Biotech Conference a New York. Il Presidente e CEO dell'azienda, Nikhil Lalwani, e il CFO Stephen Carey condurranno una conversazione informale il mercoledì 5 febbraio 2025, alle 14:00 EST.
La presentazione sarà disponibile tramite una diretta web, accessibile attraverso il sito web di ANI Pharmaceuticals nella sezione Investitori, sotto l'area Eventi e Presentazioni. Per coloro che non potranno partecipare, la registrazione della diretta rimarrà accessibile per 60 giorni dopo l'evento.
ANI Pharmaceuticals (ANIP) ha anunciado su participación en la próxima Guggenheim Biotech Conference en la ciudad de Nueva York. El Presidente y CEO de la compañía, Nikhil Lalwani, y el CFO Stephen Carey llevarán a cabo una charla informal el miércoles 5 de febrero de 2025 a las 2:00 PM EST.
La presentación estará disponible a través de una transmisión en vivo, que se podrá acceder a través del sitio web de ANI Pharmaceuticals en la sección de Inversionistas, en el área de Eventos y Presentaciones. Para aquellos que no puedan asistir, la grabación de la transmisión estará disponible por 60 días después del evento.
ANI 제약(ANIP)은 뉴욕에서 열릴 구겐하임 생명공학 컨퍼런스에 참여한다고 발표했습니다. 회사의 회장 겸 CEO인 Nikhil Lalwani와 CFO인 Stephen Carey는 2025년 2월 5일 수요일 오후 2시 EST에 대담을 진행할 예정입니다.
발표는 ANI 제약 웹사이트의 투자자 섹션의 이벤트 및 발표 영역을 통해 라이브 웹캐스트로 제공됩니다. 참석할 수 없는 분들을 위해, 웹캐스트 녹화는 이벤트 후 60일 동안 액세스할 수 있습니다.
ANI Pharmaceuticals (ANIP) a annoncé sa participation à la prochaine Guggenheim Biotech Conference à New York. Le Président et CEO de l'entreprise, Nikhil Lalwani, et le CFO Stephen Carey animeront une discussion informelle le mercredi 5 février 2025, à 14h00 EST.
La présentation sera disponible via un webinaire en direct, accessible par le biais du site web d'ANI Pharmaceuticals dans la section Investisseurs sous l'onglet Événements et Présentations. Pour ceux qui ne pourront pas y assister, l'enregistrement du webinaire restera accessible pendant 60 jours après l'événement.
ANI Pharmaceuticals (ANIP) hat seine Teilnahme an der bevorstehenden Guggenheim Biotech Conference in New York City bekannt gegeben. Der Präsident und CEO des Unternehmens, Nikhil Lalwani, und der CFO Stephen Carey werden am Mittwoch, den 5. Februar 2025, um 14:00 Uhr EST ein informelles Gespräch führen.
Die Präsentation wird über einen Live-Webcast verfügbar sein, der über die Website von ANI Pharmaceuticals im Bereich Veranstaltungen und Präsentationen der Investoren-Sektion zugänglich ist. Für diejenigen, die nicht teilnehmen können, bleibt die Aufzeichnung des Webcasts 60 Tage nach der Veranstaltung verfügbar.
- None.
- None.
PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will host a fireside chat at the Guggenheim Biotech Conference in New York City as follows:
| Date: | Wednesday, February 5, 2025 |
| Time: | 2:00pm EST |
| Webcast: | Click here |
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 60 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) presenting at the Guggenheim Biotech Conference 2025?
How long will the ANIP Guggenheim Conference webcast be available for replay?
Where can investors access the ANIP Guggenheim Conference presentation webcast?
Who will be representing ANIP at the Guggenheim Biotech Conference 2025?
